Coronary Artery Disease and Exercise Adherence
The Relationship Between Exercise Adherence, Self-Efficacy, and Health Literacy in Patients With Coronary Artery Disease: A Descriptive Correlational Study
1 other identifier
observational
208
1 country
1
Brief Summary
This study aims to determine the factors affecting exercise adherence in patients with coronary artery disease (CAD). For this purpose, the following measurement tools will be used respectively: (1) "Patient Information Form" including sociodemographic characteristics of the patients and medical information related to the disease, (2) the Exercise Adherence Rating Scale (EARS), (3) Exercise Self-Efficacy Scale (ESE) and, (4) Turkish-Health Literacy Survey Europe-Q12 (HLS-EU-19-12Q-TR). Statistical analyses will be carried out by descriptive statistics (number, percentage, mean, standard deviation, etc.), correlation analysis and regression analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedStudy Start
First participant enrolled
May 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2025
CompletedJuly 22, 2025
July 1, 2025
6 months
April 10, 2024
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
exercise adherence
EARS, a self-report measurement tool, was developed to assess adherence to prescribed home exercise regimes. It has three sections, A (qualitative information about participants' exercise adherence behaviours), B (exercise adherence behaviours) and C (factors preventing and facilitating exercise). Sections B and C are scored using a 5-point Likert scale (0=totally agree to 4=totally disagree).The total scores of Parts B and C range from 0 to 24 and 0 to 40, respectively, and the possible total scores (Part B + Part C) range from 0 to 64. A higher total score from the EARS indicates better exercise adherence. Cronbach's alpha coefficient was found to be 0.81 in the original scale and 0.86 in the Turkish version.
Baseline
predictors for exercise adherence
The following instruments will be used to measure predictors for exercise adherence: (1) patient information form, (2) ESE and, (3) HLS-EU-19-12Q-TR. The patient information form includes 14 items including sociodemographic characteristics and medical information related to the disease. The ESE has 18 items. Scores between 0-100% are obtained from the scale, the higher the score, the higher the self-efficacy level of the participants. Cronbach's alpha coefficient is 0.94. The HLS-EU-19-12Q-TR has 12 items. The total score is calculated with a standardised index score (Index=\[mean-1\]\*\[50/3\]). The standardised index score varies between 0-50. A score of 33 and over indicates adequate literacy. Correlation analyses and regression modelling will be used for the factors affecting participants' exercise adherence.
Baseline
Interventions
The data collection tools to be used in the study will be filled. It does not include any invasive or non-invasive intervention.
Eligibility Criteria
The study population refers to adults with coronary artery disease.
You may qualify if:
- A diagnosis of CAD confirmed by a physician at least one year ago,
- Individuals who have been recommended any exercise/physical activity by a physician according to item 1 of the EARS,
- Turkish comprehension and speaking skills.
You may not qualify if:
- Presence of serious physical and mental health problems,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Şeyma Demir Erbaş
Bolu, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Şeyma Demir Erbaş, PhD
Abant Izzet Baysal University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 10, 2024
First Posted
April 15, 2024
Study Start
May 13, 2024
Primary Completion
November 13, 2024
Study Completion
May 13, 2025
Last Updated
July 22, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Participant data will not be shared openly with other researchers due to the confidentiality of personal data. The primary investigator of the study can be contacted for data sharing.